{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:51:24Z","timestamp":1792122684679,"version":"4.4.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32271364"],"award-info":[{"award-number":["32271364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020756","name":"West China School of Stomatology, Sichuan University","doi-asserted-by":"publisher","award":["RD-03-202305"],"award-info":[{"award-number":["RD-03-202305"]}],"id":[{"id":"10.13039\/100020756","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Research and Development Program of China","award":["2024YFC2510700"],"award-info":[{"award-number":["2024YFC2510700"]}]},{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31971240"],"award-info":[{"award-number":["31971240"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Chem Res"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00044-025-03514-1","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T10:25:16Z","timestamp":1767781516000},"page":"316-339","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Direct targeting of GLUT1 in cancer: A decade of inhibitor discovery and medicinal chemistry insights"],"prefix":"10.1007","volume":"35","author":[{"given":"Zihan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weipeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"3514_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1146\/annurev-physiol-042022-031657","volume":"86","author":"A Klip","year":"2024","unstructured":"Klip A, De Bock K, Bilan PJ, Richter EA. Transcellular barriers to glucose delivery in the body. Annu Rev Physiol. 2024;86:149\u201373.","journal-title":"Annu Rev Physiol"},{"key":"3514_CR2","first-page":"122932","volume":"353","author":"L Zhang","year":"2024","unstructured":"Zhang L, Wu M, Zhang J, Liu T, Fu S, Wang Y, et al. The pivotal role of glucose transporter 1 in diabetic kidney disease. Life Sci. Published online. 2024;353:122932.","journal-title":"Life Sci. Published online"},{"key":"3514_CR3","doi-asserted-by":"publisher","first-page":"e38591","DOI":"10.1016\/j.heliyon.2024.e38591","volume":"10","author":"DE Rotimi","year":"2024","unstructured":"Rotimi DE, Iyobhebhe M, Oluwayemi ET, Olajide OP, Akinsanola BA, Evbuomwan IO, et al. Energy metabolism and spermatogenesis. Heliyon. 2024;10:e38591.","journal-title":"Heliyon"},{"key":"3514_CR4","doi-asserted-by":"publisher","first-page":"E141","DOI":"10.1152\/ajpendo.00712.2009","volume":"298","author":"B Thorens","year":"2010","unstructured":"Thorens B, Mueckler M. Glucose transporters in the 21st Century. Am J Physiol-Endocrinol Metab. 2010;298:E141\u2013E145. https:\/\/doi.org\/10.1152\/ajpendo.00712.2009.","journal-title":"Am J Physiol-Endocrinol Metab"},{"key":"3514_CR5","doi-asserted-by":"publisher","first-page":"e202000858","DOI":"10.26508\/lsa.202000858","volume":"4","author":"TF Cust\u00f3dio","year":"2021","unstructured":"Cust\u00f3dio TF, Paulsen PA, Frain KM, Pedersen BP. Structural comparison of GLUT1 to GLUT3 reveal transport regulation mechanism in sugar porter family. Life Sci Alliance. 2021;4:e202000858. https:\/\/doi.org\/10.26508\/lsa.202000858.","journal-title":"Life Sci Alliance"},{"key":"3514_CR6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00424-020-02411-3","volume":"472","author":"GD Holman","year":"2020","unstructured":"Holman GD. Structure, function and regulation of mammalian glucose transporters of the SLC2 family. Pflugers Arch - Eur J Physiol. 2020;472:1155\u201375. https:\/\/doi.org\/10.1007\/s00424-020-02411-3.","journal-title":"Pflugers Arch - Eur J Physiol"},{"key":"3514_CR7","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/biomedicines10061249","volume":"10","author":"R Vulturar","year":"2022","unstructured":"Vulturar R, Chi\u0219 A, Pintilie S, Farca\u0219 IM, Botezatu A, Login CC, et al. One molecule for mental nourishment and more: glucose transporter Type 1\u2014biology and deficiency syndrome. Biomedicines. 2022;10:1249. https:\/\/doi.org\/10.3390\/biomedicines10061249.","journal-title":"Biomedicines"},{"key":"3514_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2174\/0113894501335877240926101134","volume":"26","author":"S Shafi","year":"2025","unstructured":"Shafi S, Khan MA, Ahmad J, Rabbani SA, Singh S, Najmi AK. Envisioning glucose transporters (GLUTs and SGLTs) as novel intervention against cancer: drug discovery perspective and targeting approach. Curr Drug Targets. 2025;26:109\u201331.","journal-title":"Curr Drug Targets"},{"key":"3514_CR9","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3390\/nu16142363","volume":"16","author":"T Daida","year":"2024","unstructured":"Daida T, Shin BC, Cepeda C, Devaskar SU. Neurodevelopment is dependent on maternal Diet: Placenta and brain glucose transporters GLUT1 and GLUT3. Nutrients. 2024;16:2363.","journal-title":"Nutrients"},{"key":"3514_CR10","doi-asserted-by":"publisher","first-page":"5166","DOI":"10.1182\/bloodadvances.2024012743","volume":"8","author":"C Martins Freire","year":"2024","unstructured":"Martins Freire C, King NR, Dzieciatkowska M, Stephenson D, Moura PL, Dobbe JG, et al. Complete absence of GLUT1 does not impair human terminal erythroid differentiation. Blood Adv. 2024;8:5166\u201378.","journal-title":"Blood Adv"},{"key":"3514_CR11","unstructured":"Bieniasz L, Domka W, Aebisher D, Bartusik-Aebisher D. GLUT-1 overexpression in neoplastic cells. Published online 2024."},{"key":"3514_CR12","doi-asserted-by":"publisher","first-page":"e14283","DOI":"10.1111\/apha.14283","volume":"241","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Verkhratsky A, Chen H, Yi C. Understanding glucose metabolism and insulin action at the blood\u2013brain barrier: Implications for brain health and neurodegenerative diseases. Acta Physiol. 2025;241:e14283.","journal-title":"Acta Physiol"},{"key":"3514_CR13","doi-asserted-by":"publisher","first-page":"e70044","DOI":"10.1002\/jimd.70044","volume":"48","author":"J Klepper","year":"2025","unstructured":"Klepper J. Glut1 deficiency syndrome: novel pathomechanisms, current concepts, and challenges. J Inherited Metab Dis. 2025;48:e70044.","journal-title":"J Inherited Metab Dis"},{"key":"3514_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s12519-025-00884-9","volume":"21","author":"MJ Zhang","year":"2025","unstructured":"Zhang MJ, Zhang SM, Zhang QP, Wen YX, Wang JP, Jiang YW. et al. Clinical and genetic characteristics of glucose transporter 1 deficiency syndrome in a large cohort of Chinese patients. World J Pediatr. 2025;21:274\u2013283. https:\/\/doi.org\/10.1007\/s12519-025-00884-9.","journal-title":"World J Pediatr"},{"key":"3514_CR15","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.1002\/jcp.30189","volume":"236","author":"T Tsai","year":"2021","unstructured":"Tsai T, Yang C, Kou T, Yang C, Dai J, Chen C, et al. Overexpression of GLUT3 promotes metastasis of triple-negative breast cancer by modulating the inflammatory tumor microenvironment. J Cell Physiol. 2021;236:4669\u201380. https:\/\/doi.org\/10.1002\/jcp.30189.","journal-title":"J Cell Physiol"},{"key":"3514_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s10020-024-00879-8","volume":"30","author":"N Hadzi-Petrushev","year":"2024","unstructured":"Hadzi-Petrushev N, Stojchevski R, Jakimovska A, Stamenkovska M, Josifovska S, Stamatoski A, et al. GLUT5-overexpression-related tumorigenic implications. Mol Med. 2024;30:114. https:\/\/doi.org\/10.1186\/s10020-024-00879-8.","journal-title":"Mol Med"},{"key":"3514_CR17","doi-asserted-by":"publisher","first-page":"102748","DOI":"10.1016\/j.jbc.2022.102748","volume":"299","author":"X Sun","year":"2023","unstructured":"Sun X, Xue C, Jin Y, Bian C, Zhou N, Sun S. Glucose transporter GLUT1 expression is important for oriental river prawn (Macrobrachium nipponense) hemocyte adaptation to hypoxic conditions. J Biol Chem. 2023;299:102748. https:\/\/doi.org\/10.1016\/j.jbc.2022.102748.","journal-title":"J Biol Chem"},{"key":"3514_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12929-025-01167-1","volume":"32","author":"BS Pan","year":"2025","unstructured":"Pan BS, Hsu CC, Wu HE, Chen YR, Zhou X, Wang SC, et al. Glucose metabolism and its direct action in cancer and immune regulation: opportunities and challenges for metabolic targeting. J Biomed Sci. 2025;32:71. https:\/\/doi.org\/10.1186\/s12929-025-01167-1.","journal-title":"J Biomed Sci"},{"key":"3514_CR19","doi-asserted-by":"publisher","first-page":"1147676","DOI":"10.3389\/fcell.2023.1147676","volume":"11","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhang H, Liao X, Tsai HI. KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Front Cell Dev Biol. 2023;11:1147676. https:\/\/doi.org\/10.3389\/fcell.2023.1147676.","journal-title":"Front Cell Dev Biol"},{"key":"3514_CR20","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.4155\/fmc-2019-0052","volume":"11","author":"Y Meng","year":"2019","unstructured":"Meng Y, Xu X, Luan H, Li L, Dai W, Li Z, et al. The Progress and Development of GLUT1 Inhibitors Targeting Cancer Energy Metabolism. Future Med Chem. 2019;11:2333\u201352. https:\/\/doi.org\/10.4155\/fmc-2019-0052.","journal-title":"Future Med Chem"},{"key":"3514_CR21","doi-asserted-by":"publisher","unstructured":"Ahamad S, Abdulla M, Saquib M, Hussain MK. Pseudo-Natural Products: expanding chemical and biological space by surpassing natural constraints. Bioorg Chem. 2024;150:107525. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107525.","DOI":"10.1016\/j.bioorg.2024.107525"},{"key":"3514_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s43094-024-00627-z","volume":"10","author":"S Gagare","year":"2024","unstructured":"Gagare S, Patil P, Jain A. Natural product-inspired strategies towards the discovery of novel bioactive molecules. Future J Pharm Sci. 2024;10:55.","journal-title":"Future J Pharm Sci"},{"key":"3514_CR23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ijbiomac.2022.07.123","volume":"216","author":"X Chen","year":"2022","unstructured":"Chen X, Zhao Y, He C, Gao G, Li J, Qiu L, et al. Identification of a novel GLUT1 inhibitor with in vitro and in vivo anti-tumor activity. Int J Biol Macromol. 2022;216:768\u201378. https:\/\/doi.org\/10.1016\/j.ijbiomac.2022.07.123.","journal-title":"Int J Biol Macromol"},{"key":"3514_CR24","doi-asserted-by":"publisher","first-page":"108195","DOI":"10.1016\/j.carres.2020.108195","volume":"498","author":"J Fu","year":"2020","unstructured":"Fu J, Yang J, Seeberger PH, Yin J. Glycoconjugates for glucose transporter-mediated cancer-specific targeting and treatment. Carbohydr Res. 2020;498:108195. https:\/\/doi.org\/10.1016\/j.carres.2020.108195.","journal-title":"Carbohydr Res"},{"key":"3514_CR25","doi-asserted-by":"publisher","first-page":"11859","DOI":"10.2147\/IJN.S534976","volume":"ume 20","author":"Z Ren","year":"2025","unstructured":"Ren Z, Zhao J, Li S, Yuan H. Targeting glucose transporter 1 (GLUT1) in cancer: Molecular mechanisms and nanomedicine applications. IJN. 2025;ume 20:11859\u201379. https:\/\/doi.org\/10.2147\/IJN.S534976.","journal-title":"IJN"},{"key":"3514_CR26","doi-asserted-by":"publisher","unstructured":"Littleflower AB, Parambil ST, Antony GR, M S A, Subhadradevi L. Chapter Six - Glut-1 inhibition in breast cancer cells. In: Litwack G, ed. Vol 128. Vitamins and Hormones. Academic Press; 2025:181-211. https:\/\/doi.org\/10.1016\/bs.vh.2025.01.003.","DOI":"10.1016\/bs.vh.2025.01.003"},{"key":"3514_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37367-z","volume":"9","author":"T Galochkina","year":"2019","unstructured":"Galochkina T, Ng Fuk Chong M, Challali L, Abbar S, Etchebest C. New insights into GluT1 mechanics during glucose transfer. Sci Rep. 2019;9:998. https:\/\/doi.org\/10.1038\/s41598-018-37367-z.","journal-title":"Sci Rep"},{"key":"3514_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nature13306","volume":"510","author":"D Deng","year":"2014","unstructured":"Deng D, Xu C, Sun P, Wu J, Yan C, Hu M, et al. Crystal structure of the human glucose transporter GLUT1. Nature. 2014;510:121\u20135. https:\/\/doi.org\/10.1038\/nature13306.","journal-title":"Nature"},{"key":"3514_CR29","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1021\/acs.jcim.5b00597","volume":"56","author":"X Fu","year":"2016","unstructured":"Fu X, Zhang G, Liu R, Wei J, Zhang-Negrerie D, Jian X, et al. Mechanistic study of human glucose transport mediated by GLUT1. J Chem Inf Model. 2016;56:517\u201326. https:\/\/doi.org\/10.1021\/acs.jcim.5b00597.","journal-title":"J Chem Inf Model"},{"key":"3514_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/CAD.0000000000001029","volume":"32","author":"X Chen","year":"2021","unstructured":"Chen X, Zhao Y, Gao Y, Qi Y, Du J. GLUT1: a promising drug target for cancer treatment. Anti-Cancer Drugs. 2021;32:345\u201364. https:\/\/doi.org\/10.1097\/CAD.0000000000001029.","journal-title":"Anti-Cancer Drugs"},{"key":"3514_CR31","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00232-020-00108-3","volume":"253","author":"M Raja","year":"2020","unstructured":"Raja M, Kinne RKH. Mechanistic insights into protein stability and self-aggregation in GLUT1 genetic variants causing GLUT1-Deficiency syndrome. J Membrane Biol. 2020;253:87\u201399. https:\/\/doi.org\/10.1007\/s00232-020-00108-3.","journal-title":"J Membrane Biol"},{"key":"3514_CR32","doi-asserted-by":"publisher","first-page":"9734","DOI":"10.1021\/bi00030a011","volume":"34","author":"RJ Zottola","year":"1995","unstructured":"Zottola RJ, Cloherty EK, Coderre PE, Hansen A, Hebert DN, Carruthers A. Glucose transporter function is controlled by transporter oligomeric structure. A single, intramolecular disulfide promotes GLUT1 tetramerization. Biochemistry. 1995;34:9734\u201347. https:\/\/doi.org\/10.1021\/bi00030a011.","journal-title":"Biochemistry"},{"key":"3514_CR33","doi-asserted-by":"publisher","first-page":"8096","DOI":"10.1021\/bi060398x","volume":"45","author":"C Graybill","year":"2006","unstructured":"Graybill C, van Ho ek AN, Desai D, Carruthers AM, Carruthers A. Ultrastructure of human erythrocyte GLUT1. Biochemistry (Mosc). 2006;45:8096\u2013107.","journal-title":"Biochemistry (Mosc)"},{"key":"3514_CR34","doi-asserted-by":"publisher","first-page":"14600","DOI":"10.1074\/jbc.M707818200","volume":"283","author":"AA Khan","year":"2008","unstructured":"Khan AA, Hanada T, Mohseni M, Jeong JJ, Zeng L, Gaetani M, et al. Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1. J Biol Chem. 2008;283:14600\u20139. https:\/\/doi.org\/10.1074\/jbc.M707818200.","journal-title":"J Biol Chem"},{"key":"3514_CR35","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/acn3.51767","volume":"10","author":"N Tayebi","year":"2023","unstructured":"Tayebi N, Leon-Ricardo B, McCall K, Mehinovic E, Engelstad K, Huynh V, et al. Quantitative determination of SLC2A1 variant functional effects in GLUT1 deficiency syndrome. Ann Clin Transl Neurol. 2023;10:787\u2013801. https:\/\/doi.org\/10.1002\/acn3.51767.","journal-title":"Ann Clin Transl Neurol"},{"key":"3514_CR36","doi-asserted-by":"publisher","first-page":"e22428","DOI":"10.1096\/fj.202200369R","volume":"36","author":"LL Daniele","year":"2022","unstructured":"Daniele LL, Han JYS, Samuels IS, Komirisetty R, Mehta N, McCord JL, et al. Glucose uptake by GLUT1 in photoreceptors is essential for outer segment renewal and rod photoreceptor survival. FASEB J. 2022;36:e22428. https:\/\/doi.org\/10.1096\/fj.202200369R.","journal-title":"FASEB J"},{"key":"3514_CR37","doi-asserted-by":"publisher","first-page":"e1483","DOI":"10.1002\/wsbm.1483","volume":"12","author":"E Zezina","year":"2020","unstructured":"Zezina E, Sercan-Alp O, Herrmann M, Biesemann N. Glucose transporter 1 in rheumatoid arthritis and autoimmunity. Wiley Interdiscip Rev Syst Biol Med. 2020;12:e1483. https:\/\/doi.org\/10.1002\/wsbm.1483.","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"3514_CR38","doi-asserted-by":"publisher","first-page":"102515","DOI":"10.1016\/j.nano.2022.102515","volume":"42","author":"M Yang","year":"2022","unstructured":"Yang M, Walker SA, Davidovich I, Broad K, Talmon Y, Borges CR, et al. Extracellular vesicle glucose transporter-1 and glycan features in monocyte-endothelial inflammatory interactions. Nanomed Nanotechnol Biol Med. 2022;42:102515.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3514_CR39","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.7150\/ijbs.89942","volume":"20","author":"F Fontana","year":"2024","unstructured":"Fontana F, Giannitti G, Marchesi S, Limonta P. The PI3K\/Akt pathway and glucose metabolism: A dangerous liaison in cancer. Int J Biol Sci. 2024;20:3113\u201325. https:\/\/doi.org\/10.7150\/ijbs.89942.","journal-title":"Int J Biol Sci"},{"key":"3514_CR40","doi-asserted-by":"publisher","first-page":"e0257090","DOI":"10.1371\/journal.pone.0257090","volume":"16","author":"X Liu","year":"2021","unstructured":"Liu X, Yamaguchi K, Takane K, Zhu C, Hirata M, Hikiba Y, et al. Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K\/Akt\/mTORC1-Hif1\u03b1 axis. PLoS ONE. 2021;16:e0257090. https:\/\/doi.org\/10.1371\/journal.pone.0257090. Agoulnik IU, ed.","journal-title":"PLoS ONE"},{"key":"3514_CR41","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ncrna.2022.09.001","volume":"7","author":"O Beylerli","year":"2022","unstructured":"Beylerli O, Sufianova G, Shumadalova A, Zhang D, Gareev I. MicroRNAs-mediated regulation of glucose transporter (GLUT) expression in glioblastoma. Non-coding RNA Research. 2022;7:205\u201311. https:\/\/doi.org\/10.1016\/j.ncrna.2022.09.001.","journal-title":"Non-coding RNA Research"},{"key":"3514_CR42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12576-020-00773-y","volume":"70","author":"AA Mamun","year":"2020","unstructured":"Mamun AA, Hayashi H, Yamamura A, Nayeem MJ, Sato M. Hypoxia induces the translocation of glucose transporter 1 to the plasma membrane in vascular endothelial cells. J Physiol Sci. 2020;70:44. https:\/\/doi.org\/10.1186\/s12576-020-00773-y.","journal-title":"J Physiol Sci"},{"key":"3514_CR43","doi-asserted-by":"publisher","first-page":"8572","DOI":"10.3390\/ijms23158572","volume":"23","author":"S Wang","year":"2022","unstructured":"Wang S, Ning J, Huai J, Yang H. Hyperglycemia in pregnancy-associated oxidative stress augments altered placental glucose transporter 1 trafficking via AMPK\u03b1\/p38MAPK signaling cascade. IJMS. 2022;23:8572. https:\/\/doi.org\/10.3390\/ijms23158572.","journal-title":"IJMS"},{"key":"3514_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01678-8","volume":"22","author":"Z Zhou","year":"2024","unstructured":"Zhou Z, Li Y, Chen S, Xie Z, Du Y, Liu Y, et al. GLUT1 promotes cell proliferation via binds and stabilizes phosphorylated EGFR in lung adenocarcinoma. Cell Commun Signal. 2024;22:303. https:\/\/doi.org\/10.1186\/s12964-024-01678-8.","journal-title":"Cell Commun Signal"},{"key":"3514_CR45","doi-asserted-by":"publisher","first-page":"32667","DOI":"10.18632\/oncotarget.25994","volume":"9","author":"S Suzuki","year":"2018","unstructured":"Suzuki S, Okada M, Takeda H, Kuramoto K, Sanomachi T, Togashi K, et al. Involvement of GLUT1-mediated glucose transport and metabolism in gefitinib resistance of non-small-cell lung cancer cells. Oncotarget. 2018;9:32667\u201379. https:\/\/doi.org\/10.18632\/oncotarget.25994.","journal-title":"Oncotarget"},{"key":"3514_CR46","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1080\/15548627.2022.2119353","volume":"19","author":"J Yao","year":"2023","unstructured":"Yao J, Tang S, Shi C, Lin Y, Ge L, Chen Q, et al. Isoginkgetin, a potential CDK6 inhibitor, suppresses SLC2A1\/GLUT1 enhancer activity to induce AMPK-ULK1-mediated cytotoxic autophagy in hepatocellular carcinoma. Autophagy. 2023;19:1221\u201338. https:\/\/doi.org\/10.1080\/15548627.2022.2119353.","journal-title":"Autophagy"},{"key":"3514_CR47","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41368-021-00116-6","volume":"13","author":"Q Wang","year":"2021","unstructured":"Wang Q, Nie L, Zhao P, Zhou X, Ding Y, Chen Q, et al. Diabetes fuels periodontal lesions via GLUT1-driven macrophage inflammaging. Int J Oral Sci. 2021;13:11. https:\/\/doi.org\/10.1038\/s41368-021-00116-6.","journal-title":"Int J Oral Sci"},{"key":"3514_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrc3038","volume":"11","author":"WH Koppenol","year":"2011","unstructured":"Koppenol WH, Bounds PL, Dang CV. Otto Warburg\u2019s contributions to current concepts of cancer metabolism. Nat Rev Cancer. 2011;11:325\u201337. https:\/\/doi.org\/10.1038\/nrc3038.","journal-title":"Nat Rev Cancer"},{"key":"3514_CR49","doi-asserted-by":"publisher","first-page":"188705","DOI":"10.1016\/j.bbcan.2022.188705","volume":"1877","author":"K H\u00f6nigova","year":"2022","unstructured":"H\u00f6nigova K, Navratil J, Peltanova B, Polanska HH, Raudenska M, Masarik M. Metabolic tricks of cancer cells. Biochim Biophys Acta (BBA) - Rev Cancer. 2022;1877:188705. https:\/\/doi.org\/10.1016\/j.bbcan.2022.188705.","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"3514_CR50","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1111\/1759-7714.13651","volume":"11","author":"A Pezzuto","year":"2020","unstructured":"Pezzuto A, D\u2019Ascanio M, Ricci A, Pagliuca A, Carico E. Expression and role of p16 and GLUT1 in malignant diseases and lung cancer: A review. Thoracic Cancer. 2020;11:3060\u201370. https:\/\/doi.org\/10.1111\/1759-7714.13651.","journal-title":"Thoracic Cancer"},{"key":"3514_CR51","doi-asserted-by":"publisher","first-page":"8369","DOI":"10.1007\/s11033-022-07653-1","volume":"49","author":"S Dalal","year":"2022","unstructured":"Dalal S, Adhikary J, Roy A, Biswas SS, Mukhopadhyay PK, Acharya S, et al. Impact of hyperglycemia on the expression of GLUT1 during oral carcinogenesis in rats. Mol Biol Rep. 2022;49:8369\u201380. https:\/\/doi.org\/10.1007\/s11033-022-07653-1.","journal-title":"Mol Biol Rep"},{"key":"3514_CR52","unstructured":"Aayisha Neloufar Mohamed Haneef, Gopalakrishnan S, Jayaseelan VP, Ramamurthi R, Muniapillai S. GLUT1 expression in oral squamous cell carcinoma and its significance."},{"key":"3514_CR53","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1593\/tlo.11256","volume":"4","author":"YR Hussein","year":"2011","unstructured":"Hussein YR, Bandyopadhyay S, Semaan A, Ahmed Q, Albashiti B, Jazaerly T, et al. Glut-1 expression correlates with basal-like breast cancer. Transl Oncol. 2011;4:321\u20137. https:\/\/doi.org\/10.1593\/tlo.11256.","journal-title":"Transl Oncol"},{"key":"3514_CR54","doi-asserted-by":"publisher","first-page":"2283953","DOI":"10.1080\/19932820.2023.2283953","volume":"18","author":"M Hanbazazh","year":"2023","unstructured":"Hanbazazh M, Samman A, Samargandy S, Al-Maghrabi J. Prognostic value of glucose transporter proteins-1 (GLUT1) in breast carcinoma. Libyan J Med. 2023;18:2283953. https:\/\/doi.org\/10.1080\/19932820.2023.2283953.","journal-title":"Libyan J Med"},{"key":"3514_CR55","doi-asserted-by":"publisher","first-page":"2162160","DOI":"10.1080\/10717544.2022.2162160","volume":"30","author":"C Zhang","year":"2023","unstructured":"Zhang C, Liu Z, Wang F, Zhang B, Zhang X, Guo P, et al. Nanomicelles for GLUT1-targeting hepatocellular carcinoma therapy based on NADPH depletion. Drug Delivery. 2023;30:2162160. https:\/\/doi.org\/10.1080\/10717544.2022.2162160.","journal-title":"Drug Delivery"},{"key":"3514_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06274-1","volume":"14","author":"S Huang","year":"2023","unstructured":"Huang S, Wang X, Zhu Y, Wang Y, Chen J, Zheng H. SOX2 promotes vasculogenic mimicry by accelerating glycolysis via the lncRNA AC005392.2-GLUT1 axis in colorectal cancer. Cell Death Dis. 2023;14:791. https:\/\/doi.org\/10.1038\/s41419-023-06274-1.","journal-title":"Cell Death Dis"},{"key":"3514_CR57","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.7150\/jca.72161","volume":"13","author":"F Li","year":"2022","unstructured":"Li F, He C, Yao H, Liang W, Ye X, Ruan J, et al. GLUT1 regulates the tumor immune microenvironment and promotes tumor metastasis in pancreatic adenocarcinoma via ncRNA-mediated network. J Cancer. 2022;13:2540\u201358. https:\/\/doi.org\/10.7150\/jca.72161.","journal-title":"J Cancer"},{"key":"3514_CR58","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.2967\/jnumed.112.115436","volume":"54","author":"KH Jung","year":"2013","unstructured":"Jung KH, Lee JH, Thien Quach CH, Paik JY, Oh H, Park JW, et al. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species\u2013mediated hypoxia-inducible factor-1\u03b1 activation. J Nucl Med. 2013;54:2161\u20137. https:\/\/doi.org\/10.2967\/jnumed.112.115436.","journal-title":"J Nucl Med"},{"key":"3514_CR59","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1111\/1440-1681.13017","volume":"45","author":"H Wu","year":"2018","unstructured":"Wu H, He L, Shi J, Hou X, Zhang H, Zhang X, et al. Resveratrol inhibits VEGF -induced angiogenesis in human endothelial cells associated with suppression of aerobic glycolysis via modulation of PKM 2 nuclear translocation. Clin Exp Pharma Physio. 2018;45:1265\u201373. https:\/\/doi.org\/10.1111\/1440-1681.13017.","journal-title":"Clin Exp Pharma Physio"},{"key":"3514_CR60","doi-asserted-by":"publisher","first-page":"C90","DOI":"10.1152\/ajpcell.00387.2012","volume":"305","author":"M Salas","year":"2013","unstructured":"Salas M, Obando P, Ojeda L, Ojeda P, P\u00e9rez A, Vargas-Uribe M, et al. Resolution of the direct interaction with and inhibition of the human GLUT1 hexose transporter by resveratrol from its effect on glucose accumulation. Am J Physiol Cell Physiol. 2013;305:C90\u2013C99. https:\/\/doi.org\/10.1152\/ajpcell.00387.2012.","journal-title":"Am J Physiol Cell Physiol"},{"key":"3514_CR61","doi-asserted-by":"publisher","first-page":"6162","DOI":"10.1002\/jcb.26822","volume":"119","author":"Y Liu","year":"2018","unstructured":"Liu Y, Tong L, Luo Y, Li X, Chen G, Wang Y. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK\/mTOR signaling pathway. J of Cellular Biochemistry. 2018;119:6162\u201372. https:\/\/doi.org\/10.1002\/jcb.26822.","journal-title":"J of Cellular Biochemistry"},{"key":"3514_CR62","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1002\/ardp.201400159","volume":"347","author":"J Hern\u00e1ndez-Dami\u00e1n","year":"2014","unstructured":"Hern\u00e1ndez-Dami\u00e1n J, And\u00e9rica-Romero AC, Pedraza-Chaverri J. Paradoxical cellular effects and biological role of the multifaceted compound nordihydroguaiaretic acid. Archiv der Pharmazie. 2014;347:685\u201397. https:\/\/doi.org\/10.1002\/ardp.201400159.","journal-title":"Archiv der Pharmazie"},{"key":"3514_CR63","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1002\/2211-5463.12106","volume":"6","author":"D Leon","year":"2016","unstructured":"Leon D, Parada D, Vargas-Uribe M, Perez AA, Ojeda L, Zambrano A, et al. Effect of nordihydroguaiaretic acid on cell viability and glucose transport in human leukemic cell lines. FEBS Open Bio. 2016;6:1000\u20137. https:\/\/doi.org\/10.1002\/2211-5463.12106.","journal-title":"FEBS Open Bio"},{"key":"3514_CR64","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.sjbs.2019.07.005","volume":"26","author":"L Ren","year":"2019","unstructured":"Ren L. Protective effect of ganoderic acid against the streptozotocin induced diabetes, inflammation, hyperlipidemia and microbiota imbalance in diabetic rats. Saudi J Biol Sci. 2019;26:1961\u201372. https:\/\/doi.org\/10.1016\/j.sjbs.2019.07.005.","journal-title":"Saudi J Biol Sci"},{"key":"3514_CR65","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ejphar.2018.01.026","volume":"824","author":"Z Liu","year":"2018","unstructured":"Liu Z, Li L, Xue B. Effect of ganoderic acid D on colon cancer Warburg effect: Role of SIRT3\/cyclophilin D. Eur J Pharmacol. 2018;824:72\u201377. https:\/\/doi.org\/10.1016\/j.ejphar.2018.01.026.","journal-title":"Eur J Pharmacol"},{"key":"3514_CR66","doi-asserted-by":"publisher","first-page":"28569","DOI":"10.1039\/D4RA04454A","volume":"14","author":"MA Bashir","year":"2024","unstructured":"Bashir MA, Abdalla M, Shao CS, Wang H, Bondzie-Quaye P, Almahi WA, et al. Dual inhibitory potential of ganoderic acid A on GLUT1\/3: computational and in vitro insights into targeting glucose metabolism in human lung cancer. RSC Adv. 2024;14:28569\u201384. https:\/\/doi.org\/10.1039\/D4RA04454A.","journal-title":"RSC Adv"},{"key":"3514_CR67","doi-asserted-by":"publisher","first-page":"3894","DOI":"10.3892\/mmr.2017.7048","volume":"16","author":"X Wang","year":"2017","unstructured":"Wang X, Sun D, Tai J, Wang L. Ganoderic acid A inhibits proliferation and invasion, and promotes apoptosis in human hepatocellular carcinoma cells. Mol Med Rep. 2017;16:3894\u20133900. https:\/\/doi.org\/10.3892\/mmr.2017.7048.","journal-title":"Mol Med Rep"},{"key":"3514_CR68","doi-asserted-by":"publisher","first-page":"312","DOI":"10.3892\/ol.2021.12573","volume":"21","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zhang J, Xu Q, Wang B, Yao Y, Sun L, et al. YAP promotes the proliferation and migration of colorectal cancer cells through the Glut3\/AMPK signaling pathway. Oncol Lett. 2021;21:312. https:\/\/doi.org\/10.3892\/ol.2021.12573.","journal-title":"Oncol Lett"},{"key":"3514_CR69","doi-asserted-by":"publisher","first-page":"155675","DOI":"10.1016\/j.phymed.2024.155675","volume":"129","author":"B Luo","year":"2024","unstructured":"Luo B, Song L, Chen L, Cai Y, Zhang M, Wang S. Ganoderic acid D attenuates gemcitabine resistance of triple-negative breast cancer cells by inhibiting glycolysis via HIF-1\u03b1 destabilization. Phytomedicine. 2024;129:155675. https:\/\/doi.org\/10.1016\/j.phymed.2024.155675.","journal-title":"Phytomedicine"},{"key":"3514_CR70","doi-asserted-by":"publisher","first-page":"502","DOI":"10.13461\/j.cnki.cja.004825","volume":"36","author":"W Huan","year":"2011","unstructured":"Huan W, Chen H, Jia W, Fu HL, Xu JH, Jiang H, et al. Structure identification and anti-tumor activity research of FW-04-806. Chin J Antibiot. 2011;36:502\u20136. https:\/\/doi.org\/10.13461\/j.cnki.cja.004825.","journal-title":"Chin J Antibiot"},{"key":"3514_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-13-150","volume":"13","author":"W Huang","year":"2014","unstructured":"Huang W, Ye M, Zhang LR, Wu QD, Zhang M, Xu JH, et al. FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation. Mol Cancer. 2014;13:150. https:\/\/doi.org\/10.1186\/1476-4598-13-150.","journal-title":"Mol Cancer"},{"key":"3514_CR72","doi-asserted-by":"publisher","first-page":"15940","DOI":"10.18632\/oncotarget.3612","volume":"6","author":"LY Li","year":"2015","unstructured":"Li LY, Jiang H, Xie YM, Liao LD, Cao HH, Xu XE, et al. Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking \u03b21 integrin activation. Oncotarget. 2015;6:15940\u201352. https:\/\/doi.org\/10.18632\/oncotarget.3612.","journal-title":"Oncotarget"},{"key":"3514_CR73","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41418-022-01104-x","volume":"30","author":"YF Cao","year":"2023","unstructured":"Cao YF, Xie L, Tong BB, Chu MY, Shi WQ, Li X, et al. Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. Cell Death Differ. 2023;30:527\u201343. https:\/\/doi.org\/10.1038\/s41418-022-01104-x.","journal-title":"Cell Death Differ"},{"key":"3514_CR74","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.3390\/molecules24112159","volume":"24","author":"S Almahmoud","year":"2019","unstructured":"Almahmoud S, Wang X, Vennerstrom JL, Zhong HA. Conformational studies of glucose transporter 1 (GLUT1) as an anticancer drug target. Molecules. 2019;24:2159. https:\/\/doi.org\/10.3390\/molecules24112159.","journal-title":"Molecules"},{"key":"3514_CR75","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1111\/febs.16545","volume":"289","author":"X Li","year":"2022","unstructured":"Li X, Li L, Wu X, Wen B, Lin W, Cao Y, et al. Anti-tumour effects of a macrolide analog F806 in oesophageal squamous cell carcinoma cells by targeting and promoting GLUT1 autolysosomal degradation. FEBS J. 2022;289:6782\u201398. https:\/\/doi.org\/10.1111\/febs.16545.","journal-title":"FEBS J"},{"key":"3514_CR76","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1042\/bj2910861","volume":"291","author":"H Katagiri","year":"1993","unstructured":"Katagiri H, Asano T, Ishihara H, Lin JL, Inukai K, Shanahan MF, et al. Role of tryptophan-388 of GLUT1 glucose transporter in glucose-transport activity and photoaffinity-labelling with forskolin. Biochem J. 1993;291:861\u20137. https:\/\/doi.org\/10.1042\/bj2910861.","journal-title":"Biochem J"},{"key":"3514_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-38401-z","volume":"14","author":"JM Park","year":"2023","unstructured":"Park JM, Lee DH, Kim DH. Redefining the role of AMPK in autophagy and the energy stress response. Nat Commun. 2023;14:2994. https:\/\/doi.org\/10.1038\/s41467-023-38401-z.","journal-title":"Nat Commun"},{"key":"3514_CR78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.jnatprod.3c00613","volume":"87","author":"J Zhang","year":"2024","unstructured":"Zhang J, Xu X, Zhao Y, Ren C, Gu M, Zhang H, et al. Target separation and potential anticancer activity of withanolide-based glucose transporter protein 1 inhibitors from physalis angulata var. villosa. J Nat Prod. 2024;87:2\u201313. https:\/\/doi.org\/10.1021\/acs.jnatprod.3c00613.","journal-title":"J Nat Prod"},{"key":"3514_CR79","doi-asserted-by":"publisher","first-page":"C827","DOI":"10.1152\/ajpcell.00001.2015","volume":"308","author":"JM Sage","year":"2015","unstructured":"Sage JM, Cura AJ, Lloyd KP, Carruthers A. Caffeine inhibits glucose transport by binding at the GLUT1 nucleotide-binding site. Am J Physiol-Cell Physiol. 2015;308:C827\u2013C834. https:\/\/doi.org\/10.1152\/ajpcell.00001.2015.","journal-title":"Am J Physiol-Cell Physiol"},{"key":"3514_CR80","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.biochi.2017.03.011","volume":"137","author":"LK Gunnink","year":"2017","unstructured":"Gunnink LK, Busscher BM, Wodarek JA, Rosette KA, Strohbehn LE, Looyenga BD, et al. Caffeine inhibition of GLUT1 is dependent on the activation state of the transporter. Biochimie. 2017;137:99\u2013105. https:\/\/doi.org\/10.1016\/j.biochi.2017.03.011.","journal-title":"Biochimie"},{"key":"3514_CR81","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1080\/00021369.1981.10864857","volume":"45","author":"T Tanaka","year":"1981","unstructured":"Tanaka T, Kohda H, Tanaka O, Chen FH, Chou WH, Leu JL. Rubusoside (\u03b2- d -Glucosyl Ester of 13- O -\u03b2- d -Glucosyl-steviol), a Sweet Principle of Rubus chingii Hu (Rosaceae). Agric Biol Chem. 1981;45:2165\u20136. https:\/\/doi.org\/10.1080\/00021369.1981.10864857.","journal-title":"Agric Biol Chem"},{"key":"3514_CR82","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1021\/jf103497p","volume":"59","author":"GY Koh","year":"2011","unstructured":"Koh GY, McCutcheon K, Zhang F, Liu D, Cartwright CA, Martin R, et al. Improvement of obesity phenotype by chinese sweet Leaf Tea (Rubus suavissimus) components in high-fat diet-induced obese rats. J Agric Food Chem. 2011;59:98\u2013104. https:\/\/doi.org\/10.1021\/jf103497p.","journal-title":"J Agric Food Chem"},{"key":"3514_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/srep12804","volume":"5","author":"AM George Thompson","year":"2015","unstructured":"George Thompson AM, Iancu CV, Nguyen TTH, Kim D, Choe JY. Inhibition of human GLUT1 and GLUT5 by plant carbohydrate products; insights into transport specificity. Sci Rep. 2015;5:12804. https:\/\/doi.org\/10.1038\/srep12804.","journal-title":"Sci Rep"},{"key":"3514_CR84","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1021\/acschembio.6b00304","volume":"11","author":"PMU Ung","year":"2016","unstructured":"Ung PMU, Song W, Cheng L, Zhao X, Hu H, Chen L, et al. Inhibitor discovery for the human GLUT1 from homology modeling and virtual screening. ACS Chem Biol. 2016;11:1908\u201316. https:\/\/doi.org\/10.1021\/acschembio.6b00304.","journal-title":"ACS Chem Biol"},{"key":"3514_CR85","doi-asserted-by":"publisher","first-page":"112603","DOI":"10.1016\/j.ejmech.2020.112603","volume":"202","author":"K Tilekar","year":"2020","unstructured":"Tilekar K, Upadhyay N, Hess JD, Macias LH, Mrowka P, Aguilera RJ, et al. Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential. Eur J Med Chem. 2020;202:112603. https:\/\/doi.org\/10.1016\/j.ejmech.2020.112603.","journal-title":"Eur J Med Chem"},{"key":"3514_CR86","doi-asserted-by":"publisher","first-page":"1934578X2110692","DOI":"10.1177\/1934578X211069230","volume":"17","author":"XY Hu","year":"2022","unstructured":"Hu XY, Chang Y, Xu ZZ, Wang Y, Dai MM, Yu KK, et al. Rubusoside reduces blood glucose and inhibits oxidative stress by activating the AMPK signaling pathway in type 2 diabetes mellitus mice. Nat Prod Commun. 2022;17:1934578X211069230. https:\/\/doi.org\/10.1177\/1934578X211069230.","journal-title":"Nat Prod Commun"},{"key":"3514_CR87","doi-asserted-by":"publisher","first-page":"153475","DOI":"10.1016\/j.tox.2023.153475","volume":"488","author":"Y Sun","year":"2023","unstructured":"Sun Y, Duan X, Wang F, Tan H, Hu J, Bai W, et al. Inhibitory effects of flavonoids on glucose transporter 1 (GLUT1): From library screening to biological evaluation to structure-activity relationship. Toxicology. 2023;488:153475. https:\/\/doi.org\/10.1016\/j.tox.2023.153475.","journal-title":"Toxicology"},{"key":"3514_CR88","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1042\/BJ20040703","volume":"386","author":"P Strobel","year":"2005","unstructured":"Strobel P, Allard C, Perez-Acle T, Calderon R, Aldunate R, Leighton F. Myricetin, quercetin and catechin-gallate inhibit glucose uptake in isolated rat adipocytes. Biochem J. 2005;386:471\u20138.","journal-title":"Biochem J"},{"key":"3514_CR89","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.biochi.2018.05.012","volume":"151","author":"KE Hamilton","year":"2018","unstructured":"Hamilton KE, Rekman JF, Gunnink LK, Busscher BM, Scott JL, Tidball AM, Stehouwer NR, Johnecheck GN, Looyenga BD, Louters LL. Quercetin inhibits glucose transport by binding to an exofacial site on GLUT1. Biochimie. 2018;151:107\u2013114. https:\/\/doi.org\/10.1016\/j.biochi.2018.05.012.","journal-title":"Biochimie"},{"key":"3514_CR90","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.freeradbiomed.2011.01.005","volume":"50","author":"E Vlachodimitropoulou","year":"2011","unstructured":"Vlachodimitropoulou E, Sharp PA, Naftalin RJ. Quercetin\u2013iron chelates are transported via glucose transporters. Free Radical Biol Med. 2011;50:934\u201344. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2011.01.005.","journal-title":"Free Radical Biol Med"},{"key":"3514_CR91","doi-asserted-by":"publisher","first-page":"5797","DOI":"10.1074\/jbc.M509422200","volume":"281","author":"P Cunningham","year":"2006","unstructured":"Cunningham P, Afzal-Ahmed I, Naftalin RJ. Docking studies show that D-Glucose and quercetin slide through the transporter GLUT1. J Biol Chem. 2006;281:5797\u2013803. https:\/\/doi.org\/10.1074\/jbc.M509422200.","journal-title":"J Biol Chem"},{"key":"3514_CR92","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1021\/bi001660j","volume":"40","author":"JC Vera","year":"2001","unstructured":"Vera JC, Reyes AM, Vel\u00e1squez FV, Rivas CI, Zhang RH, Strobel P, et al. Direct inhibition of the hexose transporter GLUT1 by tyrosine kinase inhibitors. Biochemistry (Mosc). 2001;40:777\u201390.","journal-title":"Biochemistry (Mosc)"},{"key":"3514_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22174-4","volume":"12","author":"M Grigalunas","year":"2021","unstructured":"Grigalunas M, Burhop A, Zinken S, Pahl A, Gally JM, Wild N, et al. Natural product fragment combination to performance-diverse pseudo-natural products. Nat Commun. 2021;12:1883.","journal-title":"Nat Commun"},{"key":"3514_CR94","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/s41557-018-0132-6","volume":"10","author":"G Karageorgis","year":"2018","unstructured":"Karageorgis G, Reckzeh ES, Ceballos J, Schwalfenberg M, Sievers S, Ostermann C, et al. Chromopynones are pseudo natural product glucose uptake inhibitors targeting glucose transporters GLUT-1 and -3. Nature Chem. 2018;10:1103\u201311. https:\/\/doi.org\/10.1038\/s41557-018-0132-6.","journal-title":"Nature Chem"},{"key":"3514_CR95","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1002\/anie.201909518","volume":"58","author":"J Ceballos","year":"2019","unstructured":"Ceballos J, Schwalfenberg M, Karageorgis G, Reckzeh ES, Sievers S, Ostermann C, et al. Synthesis of Indomorphan Pseudo-Natural Product Inhibitors of Glucose Transporters GLUT-1 and -3. Angew Chem Int Ed. 2019;58:17016\u201325. https:\/\/doi.org\/10.1002\/anie.201909518.","journal-title":"Angew Chem Int Ed"},{"key":"3514_CR96","doi-asserted-by":"publisher","first-page":"94ra70","DOI":"10.1126\/scitranslmed.3002394","volume":"3","author":"DA Chan","year":"2011","unstructured":"Chan DA, Sutphin PD, Nguyen P, Turcotte S, Lai EW, Banh A, et al. Targeting GLUT1 and the warburg effect in renal cell carcinoma by chemical synthetic lethality. Sci Transl Med. 2011;3:94ra70. https:\/\/doi.org\/10.1126\/scitranslmed.3002394.","journal-title":"Sci Transl Med"},{"key":"3514_CR97","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1021\/cb500347p","volume":"9","author":"DJ Adams","year":"2014","unstructured":"Adams DJ, Ito D, Rees MG, Seashore-Ludlow B, Puyang X, Ramos AH, et al. NAMPT Is the Cellular Target of STF-31-Like Small-Molecule Probes. ACS Chem Biol. 2014;9:2247\u201354. https:\/\/doi.org\/10.1021\/cb500347p.","journal-title":"ACS Chem Biol"},{"key":"3514_CR98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.5966\/sctm.2014-0163","volume":"4","author":"EM Kropp","year":"2015","unstructured":"Kropp EM, Oleson BJ, Broniowska KA, Bhattacharya S, Chadwick AC, Diers AR, et al. Inhibition of an NAD+ salvage pathway provides efficient and selective toxicity to human pluripotent stem cells. Stem Cells Transl Med. 2015;4:483\u201393. https:\/\/doi.org\/10.5966\/sctm.2014-0163.","journal-title":"Stem Cells Transl Med"},{"key":"3514_CR99","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s13402-018-0385-5","volume":"41","author":"D Kraus","year":"2018","unstructured":"Kraus D, Reckenbeil J, Veit N, Kuerpig S, Meisenheimer M, Beier I, et al. Targeting glucose transport and the NAD pathway in tumor cells with STF-31: a re-evaluation. Cell Oncol. 2018;41:485\u201394. https:\/\/doi.org\/10.1007\/s13402-018-0385-5.","journal-title":"Cell Oncol"},{"key":"3514_CR100","doi-asserted-by":"publisher","first-page":"A85","DOI":"10.1016\/j.rhum.2023.10.130","volume":"90","author":"S Carrabin","year":"2023","unstructured":"Carrabin S, Slitine I, Bouchemla Z, Ea HK, Cohen-Solal M, Richette P, et al. L\u2019inhibition du transporteur de glucose GLUT1 fragilise le chondrocyte et aggrave l\u2019arthrose murine. Rev Rhum. 2023;90:A85\u2013A86. https:\/\/doi.org\/10.1016\/j.rhum.2023.10.130.","journal-title":"Rev Rhum"},{"key":"3514_CR101","doi-asserted-by":"publisher","first-page":"8106","DOI":"10.3390\/molecules27228106","volume":"27","author":"HC Hung","year":"2022","unstructured":"Hung HC, Li LC, Guh JH, Kung FL, Hsu LC. Discovery of new glucose uptake inhibitors as potential anticancer agents by non-radioactive cell-based assays. Molecules. 2022;27:8106. https:\/\/doi.org\/10.3390\/molecules27228106.","journal-title":"Molecules"},{"key":"3514_CR102","doi-asserted-by":"publisher","first-page":"879748","DOI":"10.3389\/fphar.2022.879748","volume":"13","author":"HC Weng","year":"2022","unstructured":"Weng HC, Sung CJ, Hsu JL, Leu WJ, Guh JH, Kung FL, et al. The combination of a novel GLUT1 inhibitor and cisplatin synergistically inhibits breast cancer cell growth by enhancing the DNA damaging effect and modulating the Akt\/mTOR and MAPK signaling pathways. Front Pharmacol. 2022;13:879748. https:\/\/doi.org\/10.3389\/fphar.2022.879748.","journal-title":"Front Pharmacol"},{"key":"3514_CR103","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.chembiol.2019.05.009","volume":"26","author":"SA Kang","year":"2019","unstructured":"Kang SA, O\u2019Neill DJ, Machl AW, Lumpkin CJ, Galda SN, Sengupta S, et al. Discovery of small-molecule selective mTORC1 inhibitors via direct inhibition of glucose transporters. Cell Chem Biol. 2019;26:1203\u201313.e13. https:\/\/doi.org\/10.1016\/j.chembiol.2019.05.009.","journal-title":"Cell Chem Biol"},{"key":"3514_CR104","doi-asserted-by":"publisher","first-page":"101766","DOI":"10.1016\/j.tice.2022.101766","volume":"76","author":"L Liu","year":"2022","unstructured":"Liu L, Xie H, Zhao S, Huang X. The GLUT1\u2013mTORC1 axis affects odontogenic differentiation of human dental pulp stem cells. Tissue Cell. 2022;76:101766. https:\/\/doi.org\/10.1016\/j.tice.2022.101766.","journal-title":"Tissue Cell"},{"key":"3514_CR105","doi-asserted-by":"publisher","first-page":"115395","DOI":"10.1016\/j.bmc.2020.115395","volume":"28","author":"S Almahmoud","year":"2020","unstructured":"Almahmoud S, Jin W, Geng L, Wang J, Wang X, Vennerstrom JL, et al. Ligand-based design of GLUT inhibitors as potential antitumor agents. Bioorg Med Chem. 2020;28:115395. https:\/\/doi.org\/10.1016\/j.bmc.2020.115395.","journal-title":"Bioorg Med Chem"},{"key":"3514_CR106","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1002\/cmdc.201600276","volume":"11","author":"H Siebeneicher","year":"2016","unstructured":"Siebeneicher H, Cleve A, Rehwinkel H, Neuhaus R, Heisler I, M\u00fcller T, et al. Identification and optimization of the first highly selective GLUT1 inhibitor BAY-876. ChemMedChem. 2016;11:2261\u201371. https:\/\/doi.org\/10.1002\/cmdc.201600276.","journal-title":"ChemMedChem"},{"key":"3514_CR107","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1186\/s12885-025-14141-9","volume":"25","author":"M Hayashi","year":"2025","unstructured":"Hayashi M, Nakamura K, Harada S, Tanaka M, Kobayashi A, Saito H. et al. GLUT1 inhibition by BAY-876 induces metabolic changes and cell death in human colorectal cancer cells. BMC cancer. 2025;25:716 https:\/\/doi.org\/10.1186\/s12885-025-14141-9.","journal-title":"BMC cancer"},{"key":"3514_CR108","doi-asserted-by":"publisher","unstructured":"Schumacher TJ, Iyer AV, Rumbley J, Ronayne CT, Mereddy VR Repurposing mitochondrial-targeting anthelmintic agents with GLUT1 inhibitor BAY-876 for cancer therapy. Cancer Biology. Preprint posted online May 5, 2024. https:\/\/doi.org\/10.1101\/2024.05.02.592272.","DOI":"10.1101\/2024.05.02.592272"},{"key":"3514_CR109","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1158\/1535-7163.MCT-21-0925","volume":"21","author":"L Guo","year":"2022","unstructured":"Guo L, Zhang W, Xie Y, Chen X, Olmstead EE, Lian M, et al. Diaminobutoxy-substituted isoflavonoid (DBI-1) enhances the therapeutic efficacy of GLUT1 inhibitor BAY-876 by modulating metabolic pathways in colon cancer cells. Mol Cancer Ther. 2022;21:740\u201350. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0925.","journal-title":"Mol Cancer Ther"},{"key":"3514_CR110","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41420-024-02106-z","volume":"10","author":"ZA Miller","year":"2024","unstructured":"Miller ZA, Muthuswami S, Mueller A, Ma RZ, Sywanycz SM, Naik A, et al. GLUT1 inhibitor BAY-876 induces apoptosis and enhances anti-cancer effects of bitter receptor agonists in head and neck squamous carcinoma cells. Cell Death Discov. 2024;10:339. https:\/\/doi.org\/10.1038\/s41420-024-02106-z.","journal-title":"Cell Death Discov"},{"key":"3514_CR111","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1016\/j.bmcl.2010.02.027","volume":"20","author":"W Zhang","year":"2010","unstructured":"Zhang W, Liu Y, Chen X, Bergmeier SC. Novel inhibitors of basal glucose transport as potential anticancer agents. Bioorg Med Chem Lett. 2010;20:2191\u20134. https:\/\/doi.org\/10.1016\/j.bmcl.2010.02.027.","journal-title":"Bioorg Med Chem Lett"},{"key":"3514_CR112","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.canlet.2010.07.002","volume":"298","author":"Y Liu","year":"2010","unstructured":"Liu Y, Zhang W, Cao Y, Liu Y, Bergmeier S, Chen X. Small compound inhibitors of basal glucose transport inhibit cell proliferation and induce apoptosis in cancer cells via glucose-deprivation-like mechanisms. Cancer Lett. 2010;298:176\u201385. https:\/\/doi.org\/10.1016\/j.canlet.2010.07.002.","journal-title":"Cancer Lett"},{"key":"3514_CR113","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, et al. A small-molecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther. 2012;11:1672\u201382. https:\/\/doi.org\/10.1158\/1535-7163.MCT-12-0131.","journal-title":"Mol Cancer Ther"},{"key":"3514_CR114","doi-asserted-by":"publisher","unstructured":"Geng H, Chen L, Lv S, Li M, Huang X, Li M, et al. Photochemically controlled release of the glucose transporter 1 inhibitor for glucose deprivation responses and cancer suppression research. J Proteome Res. Published online January 3, 2024:acs.jproteome.3c00469. https:\/\/doi.org\/10.1021\/acs.jproteome.3c00469.","DOI":"10.1021\/acs.jproteome.3c00469"},{"key":"3514_CR115","doi-asserted-by":"publisher","first-page":"106789","DOI":"10.1016\/j.ejps.2024.106789","volume":"198","author":"C Wang","year":"2024","unstructured":"Wang C, Li Z, Zhai H, Shen X, Li F, Zhang Q, et al. Targeted blocking of EGFR and GLUT1 by compound H reveals a new strategy for treatment of triple-negative breast cancer and nasopharyngeal carcinoma. Eur J Pharm Sci. 2024;198:106789. https:\/\/doi.org\/10.1016\/j.ejps.2024.106789.","journal-title":"Eur J Pharm Sci"},{"key":"3514_CR116","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ijbiomac.2019.09.077","volume":"142","author":"N Fayyazi","year":"2020","unstructured":"Fayyazi N, Fassihi A, Esmaeili S, Taheri S, Ghasemi JB, Saghaie L. Molecular dynamics simulation and 3D-pharmacophore analysis of new quinoline-based analogues with dual potential against EGFR and VEGFR-2. Int J Biol Macromol. 2020;142:94\u2013113. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.09.077.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3514_CR117","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/9780470559277.ch110180","volume":"3","author":"B Lomenick","year":"2011","unstructured":"Lomenick B, Hao R, Jonai N, Chin RM, Aghajan M, Warburton S. et al. Target identification using drug affinity responsive target stability (DARTS). Curr protoc chem biol. 2011;3(4):163\u2013180. https:\/\/doi.org\/10.1002\/9780470559277.ch110180.","journal-title":"Curr protoc chem biol"},{"key":"3514_CR118","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1038\/s41388-020-01402-z","volume":"39","author":"H Yang","year":"2020","unstructured":"Yang H, Geng YH, Wang P, Yang H, Zhou YT, Zhang HQ, et al. Extracellular ATP promotes breast cancer invasion and chemoresistance via SOX9 signaling. Oncogene. 2020;39:5795\u2013810. https:\/\/doi.org\/10.1038\/s41388-020-01402-z.","journal-title":"Oncogene"},{"key":"3514_CR119","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.toxlet.2019.02.013","volume":"307","author":"M Songbo","year":"2019","unstructured":"Songbo M, Lang H, Xinyong C, Bin X, Ping Z, Liang S. Oxidative stress injury in doxorubicin-induced cardiotoxicity. Toxicol Lett. 2019;307:41\u201348. https:\/\/doi.org\/10.1016\/j.toxlet.2019.02.013.","journal-title":"Toxicol Lett"},{"key":"3514_CR120","unstructured":"Chen CS, Wang D, Kulp SK. Glucose Transporter Inhibitors. Google Patents; 2015."},{"key":"3514_CR121","doi-asserted-by":"publisher","first-page":"3546","DOI":"10.1158\/1535-7163.MCT-08-0569","volume":"7","author":"TE Wood","year":"2008","unstructured":"Wood TE, Dalili S, Simpson CD, Hurren R, Mao X, Saiz FS, et al. A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death. Mol Cancer Ther. 2008;7:3546\u201355. https:\/\/doi.org\/10.1158\/1535-7163.MCT-08-0569.","journal-title":"Mol Cancer Ther"},{"key":"3514_CR122","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.1016\/j.ejmech.2010.07.014","volume":"45","author":"V Patil","year":"2010","unstructured":"Patil V, Tilekar K, Mehendale-Munj S, Mohan R, Ramaa CS. Synthesis and primary cytotoxicity evaluation of new 5-benzylidene-2,4-thiazolidinedione derivatives. Eur J Med Chem. 2010;45:4539\u201344. https:\/\/doi.org\/10.1016\/j.ejmech.2010.07.014.","journal-title":"Eur J Med Chem"},{"key":"3514_CR123","doi-asserted-by":"publisher","first-page":"105512","DOI":"10.1016\/j.ejps.2020.105512","volume":"154","author":"K Tilekar","year":"2020","unstructured":"Tilekar K, Upadhyay N, Schweipert M, Hess JD, Macias LH, Mrowka P, et al. Permuted 2,4-thiazolidinedione (TZD) analogs as GLUT inhibitors and their in-vitro evaluation in leukemic cells. Eur J Pharm Sci. 2020;154:105512. https:\/\/doi.org\/10.1016\/j.ejps.2020.105512.","journal-title":"Eur J Pharm Sci"},{"key":"3514_CR124","doi-asserted-by":"publisher","first-page":"103934","DOI":"10.1016\/j.bioorg.2020.103934","volume":"100","author":"N Upadhyay","year":"2020","unstructured":"Upadhyay N, Tilekar K, J\u00e4nsch N, Schweipert M, Hess JD, Henze Macias L, et al. Discovery of novel N-substituted thiazolidinediones (TZDs) as HDAC8 inhibitors: in-silico studies, synthesis, and biological evaluation. Bioorg Chem. 2020;100:103934. https:\/\/doi.org\/10.1016\/j.bioorg.2020.103934.","journal-title":"Bioorg Chem"},{"key":"3514_CR125","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1007\/s10637-021-01109-2","volume":"39","author":"X Chen","year":"2021","unstructured":"Chen X, Zhao Y, Lyu S, Gao G, Gao Y, Qi Y, et al. Identification of novel inhibitors of GLUT1 by virtual screening and cell-based assays. Invest New Drugs. 2021;39:1242\u201355. https:\/\/doi.org\/10.1007\/s10637-021-01109-2.","journal-title":"Invest New Drugs"},{"key":"3514_CR126","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.chembiol.2019.06.005","volume":"26","author":"ES Reckzeh","year":"2019","unstructured":"Reckzeh ES, Karageorgis G, Schwalfenberg M, Ceballos J, Nowacki J, Stroet MCM, et al. Inhibition of glucose transporters and glutaminase synergistically impairs tumor cell growth. Cell Chem Biol. 2019;26:1214\u201328.e25. https:\/\/doi.org\/10.1016\/j.chembiol.2019.06.005.","journal-title":"Cell Chem Biol"},{"key":"3514_CR127","doi-asserted-by":"publisher","first-page":"11262","DOI":"10.1080\/07391102.2022.2161010","volume":"41","author":"MK Temre","year":"2023","unstructured":"Temre MK, Devi B, Singh VK, Goel Y, Yadav S, Pandey SK, et al. Molecular characterization of glutor-GLUT interaction and prediction of glutor\u2019s drug-likeness: implications for its utility as an antineoplastic agent. J Biomol Struct Dyn. 2023;41:11262\u201373. https:\/\/doi.org\/10.1080\/07391102.2022.2161010.","journal-title":"J Biomol Struct Dyn"},{"key":"3514_CR128","doi-asserted-by":"publisher","first-page":"925666","DOI":"10.3389\/fonc.2022.925666","volume":"12","author":"MK Temre","year":"2022","unstructured":"Temre MK, Yadav S, Goel Y, Pandey SK, Kumar A, Singh SM. Glutor, a glucose transporter inhibitor, exerts antineoplastic action on tumor cells of thymic origin: implication of modulated metabolism, survival, oxidative stress, mitochondrial membrane potential, pH homeostasis, and chemosensitivity. Front Oncol. 2022;12:925666. https:\/\/doi.org\/10.3389\/fonc.2022.925666.","journal-title":"Front Oncol"},{"key":"3514_CR129","doi-asserted-by":"publisher","first-page":"7194","DOI":"10.1021\/ja00775a078","volume":"94","author":"SM Kupchan","year":"1972","unstructured":"Kupchan SM, Court WA, Dailey RG, Gilmore CJ, Bryan RF. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc. 1972;94:7194\u20135. https:\/\/doi.org\/10.1021\/ja00775a078. Tumor inhibitors. LXXIV.","journal-title":"J Am Chem Soc"},{"key":"3514_CR130","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.ejmech.2019.05.032","volume":"176","author":"W Hou","year":"2019","unstructured":"Hou W, Liu B, Xu HT. Triptolide: Medicinal chemistry, chemical biology and clinical progress. Eur J Med Chem. 2019;176:378\u2013392. https:\/\/doi.org\/10.1016\/j.ejmech.2019.05.032.","journal-title":"Eur J Med Chem"},{"key":"3514_CR131","doi-asserted-by":"publisher","unstructured":"Jiang SY, Wan F, Lian H, Lu ZH, Li XM, Cao D, Jiang YY, Li J. Friend or foe? The dual role of triptolide in the liver, kidney,and heart. 2023;161: 114470. https:\/\/doi.org\/10.1016\/j.biopha.2023.114470.","DOI":"10.1016\/j.biopha.2023.114470"},{"key":"3514_CR132","doi-asserted-by":"publisher","first-page":"12035","DOI":"10.1002\/anie.201606121","volume":"55","author":"Q He","year":"2016","unstructured":"He Q, Minn I, Wang Q, Xu P, Head SA, Datan E, et al. Targeted delivery and sustained antitumor activity of triptolide through glucose conjugation. Angew Chem Int Ed. 2016;55:12035\u20139. https:\/\/doi.org\/10.1002\/anie.201606121.","journal-title":"Angew Chem Int Ed"},{"key":"3514_CR133","doi-asserted-by":"publisher","first-page":"101536","DOI":"10.1016\/j.isci.2020.101536","volume":"23","author":"E Datan","year":"2020","unstructured":"Datan E, Minn I, Xu P, He QL, Ahn HH, Yu B, et al. A glucose-triptolide conjugate selectively targets cancer cells under hypoxia. iScience. 2020;23:101536. https:\/\/doi.org\/10.1016\/j.isci.2020.101536.","journal-title":"iScience"},{"key":"3514_CR134","doi-asserted-by":"publisher","first-page":"114463","DOI":"10.1016\/j.ejmech.2022.114463","volume":"238","author":"Y Liu","year":"2022","unstructured":"Liu Y, Huang JQ, Wu M, Liu B, Lin QF, Wu JJ, Ouyang YH, Guo X, Huang RY, Zhang YM, Xu JH. Design, synthesis of novel triptolide-glucose conjugates targeting glucose Transporter-1 and their selective antitumor effect. Eur J Med Chem. 2022;238:114463. https:\/\/doi.org\/10.1016\/j.ejmech.2022.114463.","journal-title":"Eur J Med Chem"},{"key":"3514_CR135","doi-asserted-by":"publisher","first-page":"152479","DOI":"10.1016\/j.cej.2024.152479","volume":"493","author":"X Wu","year":"2024","unstructured":"Wu X, Shen J, Jiang X, Han H, Li Z, Xiang Y, et al. Targeting GLUT1 degradation with assembling glycopeptide for cancer inhibition. Chem Eng J. 2024;493:152479. https:\/\/doi.org\/10.1016\/j.cej.2024.152479.","journal-title":"Chem Eng J"},{"key":"3514_CR136","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1021\/acs.jmedchem.9b00634","volume":"62","author":"P Zhang","year":"2019","unstructured":"Zhang P, Ma J, Zhang Q, Jian S, Sun X, Liu B, et al. Monosaccharide Analogues of Anticancer Peptide R-Lycosin-I: role of monosaccharide conjugation in complexation and the potential of lung cancer targeting and therapy. J Med Chem. 2019;62:7857\u201373. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b00634.","journal-title":"J Med Chem"},{"key":"3514_CR137","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-20-2870","volume":"81","author":"PB Ancey","year":"2021","unstructured":"Ancey PB, Contat C, Boivin G, Sabatino S, Pascual J, Zangger N, et al. GLUT1 expression in tumor-associated neutrophils promotes lung cancer growth and resistance to radiotherapy. Cancer Res. 2021;81:2345\u201357. https:\/\/doi.org\/10.1158\/0008-5472.CAN-20-2870.","journal-title":"Cancer Res"},{"key":"3514_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08763-y","volume":"21","author":"X Zhang","year":"2021","unstructured":"Zhang X, Pang X, Zhang Z, Liu Q, Zhang H, Xiang Q, et al. Co-expression and prognosis analyses of GLUT1\u20134 and RB1 in breast cancer. BMC Cancer. 2021;21:1026. https:\/\/doi.org\/10.1186\/s12885-021-08763-y.","journal-title":"BMC Cancer"},{"key":"3514_CR139","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1007\/s11307-010-0399-5","volume":"13","author":"M Hassanein","year":"2011","unstructured":"Hassanein M, Weidow B, Koehler E, Bakane N, Garbett S, Shyr Y, et al. Development of high-throughput quantitative assays for glucose uptake in cancer cell lines. Mol Imaging Biol. 2011;13:840\u201352. https:\/\/doi.org\/10.1007\/s11307-010-0399-5.","journal-title":"Mol Imaging Biol"},{"key":"3514_CR140","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ab.2016.04.010","volume":"505","author":"MP Valley","year":"2016","unstructured":"Valley MP, Karassina N, Aoyama N, Carlson C, Cali JJ, Vidugiriene J. A bioluminescent assay for measuring glucose uptake. Anal Biochem. 2016;505:43\u201350. https:\/\/doi.org\/10.1016\/j.ab.2016.04.010.","journal-title":"Anal Biochem"},{"key":"3514_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14129-x","volume":"7","author":"KH Tomaszowski","year":"2017","unstructured":"Tomaszowski KH, Hellmann N, Ponath V, Takatsu H, Shin HW, Kaina B. Uptake of glucose-conjugated MGMT inhibitors in cancer cells: role of flippases and type IV P-type ATPases. Sci Rep. 2017;7:13925. https:\/\/doi.org\/10.1038\/s41598-017-14129-x.","journal-title":"Sci Rep"},{"key":"3514_CR142","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik SM, Pedram K, Wisnovsky S, Ahn G, Riley NM, Bertozzi CR. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature. 2020;584:291\u20137. https:\/\/doi.org\/10.1038\/s41586-020-2545-9.","journal-title":"Nature"},{"key":"3514_CR143","doi-asserted-by":"publisher","first-page":"10848","DOI":"10.1021\/acs.jmedchem.2c00867","volume":"65","author":"R Maccari","year":"2022","unstructured":"Maccari R, Ottan\u00e0 R. Sodium-glucose cotransporter inhibitors as antidiabetic drugs: Current development and future perspectives. J Med Chem. 2022;65:10848\u201381. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00867.","journal-title":"J Med Chem"},{"key":"3514_CR144","doi-asserted-by":"publisher","first-page":"15245","DOI":"10.1016\/S0021-9258(19)37577-5","volume":"263","author":"T Kayano","year":"1988","unstructured":"Kayano T, Fukumoto H, Eddy RL, Fan YS, Byers MG, Shows TB, et al. Evidence for a family of human glucose transporter-like proteins. Sequence and gene localization of a protein expressed in fetal skeletal muscle and other tissues. J Biol Chem. 1988;263:15245\u20138. https:\/\/doi.org\/10.1016\/S0021-9258(19)37577-5.","journal-title":"J Biol Chem"},{"key":"3514_CR145","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1111\/j.1600-0854.2010.01113.x","volume":"11","author":"CA Lamb","year":"2010","unstructured":"Lamb CA, McCann RK, St\u00f6ckli J, James DE, Bryant NJ. Insulin-Regulated Trafficking of GLUT4 Requires Ubiquitination. Traffic. 2010;11:1445\u201354. https:\/\/doi.org\/10.1111\/j.1600-0854.2010.01113.x.","journal-title":"Traffic"},{"key":"3514_CR146","doi-asserted-by":"publisher","first-page":"154869","DOI":"10.1016\/j.metabol.2021.154869","volume":"123","author":"W Peng","year":"2021","unstructured":"Peng W, Tan C, Mo L, Jiang J, Zhou W, Du J, et al. Glucose transporter 3 in neuronal glucose metabolism: Health and diseases. Metabolism. 2021;123:154869. https:\/\/doi.org\/10.1016\/j.metabol.2021.154869.","journal-title":"Metabolism"},{"key":"3514_CR147","doi-asserted-by":"publisher","first-page":"e88815","DOI":"10.1172\/jci.insight.88815","volume":"2","author":"R Kuang","year":"2017","unstructured":"Kuang R, Jahangiri A, Mascharak S, Nguyen A, Chandra A, Flanigan PM, et al. GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance. JCI Insight. 2017;2:e88815. https:\/\/doi.org\/10.1172\/jci.insight.88815.","journal-title":"JCI Insight"},{"key":"3514_CR148","doi-asserted-by":"publisher","unstructured":"Wang H, Zhao W, Liu A, Wang S, Liu H, Ni Y. Targeting intestinal transporter GLUT5 to alleviate the high-fructose-induced steatotic liver disease. FEBS J. Published online November 12, 2025:febs.70338. https:\/\/doi.org\/10.1111\/febs.70338.","DOI":"10.1111\/febs.70338"},{"key":"3514_CR149","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52666-y","volume":"15","author":"JA Guerrero","year":"2024","unstructured":"Guerrero JA, Klysz DD, Chen Y, Malipatlolla M, Lone J, Fowler C, et al. GLUT1 overexpression in CAR-T cells induces metabolic reprogramming and enhances potency. Nat Commun. 2024;15:8658. https:\/\/doi.org\/10.1038\/s41467-024-52666-y.","journal-title":"Nat Commun"},{"key":"3514_CR150","doi-asserted-by":"publisher","first-page":"123178","DOI":"10.1016\/j.biomaterials.2025.123178","volume":"319","author":"K Wang","year":"2025","unstructured":"Wang K, Li L, Liang G, Xiao H, Zhang L, Liu T. Sonodynamic activated nanoparticles with Glut1 inhibitor and cystine-containing polymer stimulate disulfidptosis for improved immunotherapy in bladder cancer. Biomaterials. 2025;319:123178. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123178.","journal-title":"Biomaterials"}],"container-title":["Medicinal Chemistry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-025-03514-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00044-025-03514-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00044-025-03514-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T08:55:12Z","timestamp":1770281712000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00044-025-03514-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":150,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["3514"],"URL":"https:\/\/doi.org\/10.1007\/s00044-025-03514-1","relation":{},"ISSN":["1054-2523","1554-8120"],"issn-type":[{"value":"1054-2523","type":"print"},{"value":"1554-8120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}